GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Mengis Capital Management Inc.

Mengis Capital Management Inc. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 267.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,307 shares of the company's stock after purchasing an additional 11,875 shares during the quarter. Mengis Capital Management Inc.'s holdings in GE HealthCare Technologies were worth $1,261,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in GEHC. Vanguard Group Inc. grew its position in shares of GE HealthCare Technologies by 14.7% during the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company's stock worth $3,029,917,000 after purchasing an additional 5,693,244 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in GE HealthCare Technologies by 84.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company's stock valued at $181,578,000 after buying an additional 1,221,436 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in GE HealthCare Technologies by 1,323.5% during the 3rd quarter. Envestnet Asset Management Inc. now owns 1,024,128 shares of the company's stock valued at $69,682,000 after buying an additional 952,182 shares in the last quarter. Invesco Ltd. grew its holdings in GE HealthCare Technologies by 21.4% during the 3rd quarter. Invesco Ltd. now owns 5,048,262 shares of the company's stock valued at $343,484,000 after buying an additional 889,297 shares in the last quarter. Finally, Nordea Investment Management AB purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at approximately $55,152,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 0.2 %

Shares of GEHC stock traded down $0.18 on Monday, reaching $84.31. 2,113,742 shares of the company's stock were exchanged, compared to its average volume of 3,376,418. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of $38.47 billion, a PE ratio of 28.15, a P/E/G ratio of 2.94 and a beta of 0.95. The company's fifty day simple moving average is $88.74 and its 200 day simple moving average is $77.96.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period last year, the company earned $1.31 EPS. GE HealthCare Technologies's quarterly revenue was up 5.3% compared to the same quarter last year. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio is currently 3.97%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research analyst reports. Mizuho raised their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, April 11th. Citigroup raised their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd. Argus raised their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a report on Monday, April 1st. Evercore ISI raised their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an "outperform" rating in a research note on Thursday, April 4th. Finally, HSBC began coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a "buy" rating and a $100.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.